3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroblastoma
4
Melanoma
4
Prostatic Neoplasms
3
Neoplasm Metastasis
3
Myelodysplastic Syndromes
3
Multiple Myeloma
3
Lymphoma
3
Leukemia, Myeloid, Acute
3
Ganglioneuroblastoma
3
Uveal Melanoma
2
Osteosarcoma
2
Lymphoma, Non-Hodgkin
2
Lung Neoplasms
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Leukemia
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Sarcoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Neoplasms, Plasma Cell
1
Lymphoma, T-Cell
1
Lymphoma, Follicular
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Monocytic, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Lymphoid
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Erythroblastic, Acute
1
Kidney Neoplasms
1
Interventions
pembrolizumab
26
atezolizumab
14
Nivolumab
13
Gemcitabine
13
Cisplatin
10
Docetaxel
8
Carboplatin
8
avelumab
7
Mitomycin
7
epacadostat
4
cabozantinib
4
Ipilimumab
4
pemigatinib
3
Specimen Handling
3
Paclitaxel
3
Magnetic Resonance Spectroscopy
3
Bevacizumab
3
vofatamab
2
rucaparib
2
lenvatinib
2
enfortumab vedotin
2
durvalumab
2
cabazitaxel
2
bempegaldesleukin
2
Standard of Care
2
Rogaratinib
2
Ramucirumab
2
Radiation
2
Platinum
2
Pemetrexed
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Transitional Cell
×
Colony-Stimulating Factors
×
Clear all
No trials found.